KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Operating Expenses (2016 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Operating Expenses for 13 consecutive years, with $381.7 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 286.35% to $381.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $380.6 million through Dec 2025, up 389.92% year-over-year, with the annual reading at $380.6 million for FY2025, 12680.83% up from the prior year.
  • Operating Expenses for Q4 2025 was $381.7 million at Xenon Pharmaceuticals, up from $766000.0 in the prior quarter.
  • The five-year high for Operating Expenses was $381.7 million in Q4 2025, with the low at -$204.8 million in Q4 2024.
  • Average Operating Expenses over 5 years is $17.4 million, with a median of $24.2 million recorded in 2021.
  • Peak annual rise in Operating Expenses hit 286.35% in 2025, while the deepest fall reached 577.55% in 2025.
  • Over 5 years, Operating Expenses stood at $28.6 million in 2021, then crashed by 416.02% to -$90.3 million in 2022, then tumbled by 82.05% to -$164.4 million in 2023, then fell by 24.6% to -$204.8 million in 2024, then soared by 286.35% to $381.7 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $381.7 million, $766000.0, and -$2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.